Zanamivir (Standard)
Zanamivir (Standard) is the analytical standard of Zanamivir. This product is intended for research and analytical applications. Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 95%
- No. CAS: 139110-80-8
- Fòrmula: C12H20N4O7
- Peso molecular:332.31
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-13210
Zanamivir
-
HY-17016
Oseltamivir phosphate
-
HY-13318
Oseltamivir acid
-
HY-17015A
Peramivir
-
HY-13317
Oseltamivir
-
HY-17015
Peramivir trihydrate
-
HY-50001
Nucleozin
-
HY-17015R
Peramivir trihydrate (Standard)
-
HY-N0709
Coumarin
-
HY-P0017
Aprotinin
-
HY-14904A
Umifenovir hydrochloride
-
HY-17016R
Oseltamivir phosphate (Standard)
Product Information
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 139110-80-8
-
Peso molecular 332.31
-
Fòrmula C12H20N4O7
-
SMILES
NC(N[C@@H]1[C@H]([C@@]([H])(OC(C(O)=O)=C1)[C@@H]([C@@H](CO)O)O)NC(C)=O)=N
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Gubareva LV, et al. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates ofinfluenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother. 2001 Dec;45(12):3403-8. [Content Brief]
[2]. McKimm-Breschkin JL, et al. Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat Respir Med. 2005;4(2):107-16. [Content Brief]
[3]. Shanmugam S, et al. Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats. Biomol Ther (Seoul). 2013 Mar;21(2):161-9. [Content Brief]
Zanamivir (Standard) Related Classifications
HY-13210R Related Classifications
Powered by Bioz